NHP studies are probably complete and the information is with the analysts until the report is finalised.
The latest release has this due before the AGM.
Surely there will be a move up in the price prior to this company making release. It takes us to a 70% probability that one drug will generate sales in excess of a billion dollars per annum and probably 1-2 more drugs close behind it. And it validates the platform opening us up to major trials by larger companies.
20c by Friday this week if there is no news?
NHP studies are probably complete and the information is with...
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
0.020(1.77%) |
Mkt cap ! $670.7M | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.18 | $1.11 | $172.3K | 151.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 592 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 4211 | 1 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |